Article
11 Jun 2026
FDA Issues Draft Guidance On Payor Communications To Address Statutory Changes
AUTHORS CONTENT
Article
22 May 2026
CMS ‘Crackdown On Fraud’ Continues With Nationwide Six-Month Moratoria On New Medicare Enrollments For Hospices And Home Health Agencies
Article
06 May 2026
FDA Makes Moves To Modernize Drug Development, Clinical Trial Paradigm
Article
24 Apr 2026
Ambitious Priorities: Breaking Down FDA’s FY27 Budget
Article
13 Apr 2026
FDA Dives Deeper Into The Use Of Digital Health Technologies In Drug Development With New RFI
Article
27 Mar 2026
FDA Announces Public Hearing And Opportunity To Comment On National Priority Voucher Pilot Program
Article
19 Mar 2026
Q&A: FDA Seeks To Clarify '3-Year Exclusivity' With New Guidance
Article
26 Feb 2026
DEI Cases Receiving 'Expedited Priority Treatment' At DOJ
Article
19 Dec 2025
FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration
Article
24 Oct 2025
FDA Names The First Nine National Priority Voucher Recipients
Article
01 Oct 2025
FDA Presses Forward On PDUFA VII CGT Commitments With Release Of Draft Guidance On Clinical Trial Design, Methods For Capturing Postapproval Data
Article
10 Sep 2025
FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles
Article
01 Jul 2025
HHS To Launch Campaign Promoting Wearable Devices
Article
25 Jun 2025
FDA Announces Commissioner's National Priority Voucher Program To Accelerate Drug Application Review Process And Support National Priorities
Article
22 Jan 2025
FDA Finalizes Guidance On Communication Of Unapproved Uses Of Approved Or Cleared Medical Products
Article
08 Jan 2025
FDA's Idea Lab Seeks To Reimagine Device Use In The Home Through New Virtual Reality Prototype
Article
27 Nov 2024
FDA Announces Plan To Speed Up Public Notification About Potentially High-Risk Device Recalls
Article
13 Nov 2024
FDA Approves The First Flu Vaccine For At Home Use, Providing A Needle Free Option Outside Of Traditional Health Care Settings
Article
12 Nov 2024
FDA Amplifies Cross-Center Collaboration With The Creation Of The Rare Disease Innovation Hub